Modeling IKZF1 lesions in B-ALL reveals distinct chemosensitivity patterns and potential therapeutic vulnerabilities.
Rogers JH, Gupta R, Reyes JM, Gundry MC, Medrano G, Guzman A, Aguilar R, Conneely SE, Song T, Johnson C, Barnes S, Cristobal CDD, Kurtz K, Brunetti L, Goodell MA, Rau RE.
Rogers JH, et al. Among authors: gupta r.
Blood Adv. 2021 Oct 12;5(19):3876-3890. doi: 10.1182/bloodadvances.2020002408.
Blood Adv. 2021.
PMID: 34492683
Free PMC article.